Kenneth Thompson

Statistics

Publications

Citations

479

H-Index

Active since

2002

Affiliations

Amyotrophic Lateral Sclerosis Therapy Development Institute(Current)

Kenneth Thompson is an author at Amyotrophic Lateral Sclerosis Therapy Development Institute specializing in neurodegenerative diseases, neurodegeneration, and amyotrophic lateral sclerosis.

Publications per year

2002–2019

Publications

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Theo Hatzipetros, Joshua D. Kidd, Andy J. Moreno et al. · Journal of Visualized Experiments · 2015 · 120 citations · Full text

Life Sciences, Neurology, Neuroscience +17

From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis

John Lincecum, Fernando G. Vieira, Monica Z. Wang et al. · Nature Genetics · 2010 · 112 citations

Life Sciences, Neurobiology, Neuroscience +17

No Benefit from Chronic Lithium Dosing in a Sibling-Matched, Gender Balanced, Investigator-Blinded Trial Using a Standard Mouse Model of Familial ALS

Alan Gill, Joshua D. Kidd, Fernando G. Vieira et al. · PLoS ONE · 2009 · 83 citations · Full text

Medicine, Neurology, Pharmacology +16

SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS

Cindy Gill, James Phelan, Theo Hatzipetros et al. · Scientific Reports · 2019 · 74 citations · Full text

Life Sciences, Neurology, Neuroscience +17

CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits

Fernando G. Vieira, Theo Hatzipetros, Kenneth Thompson et al. · IBRO Reports · 2017 · 41 citations · Full text

Life Sciences, Neurology, Neuroscience +17

1–5 of 7